BackgroundCheck.run
Search For

Ronald Edward Ingram, 61Hopkinsville, KY

Known as:
Ronald E Ingram Ronald G Ingram Ron E Ingram Ronald E Imgram Ron E Imgram
Related to:
Marvin Ingram 65

Ronald Ingram Phones & Addresses

Hopkinsville, KY   

San Diego, CA   

Grenada, MS   

Get Report
Control this profile

Mentions for Ronald Edward Ingram

Career records & work history

Lawyers & Attorneys

Ronald Ingram Photo 1

Ronald Ingram - Lawyer

ISLN:
921374723
Admitted:
Texas

Medicine Doctors

Ronald W. Ingram

Specialties:
Ophthalmology
Work:
Ingram Eye Center
2706 W Cuthbert Ave STE 1A, Midland, TX 79701
432-6940999 (phone) 432-6947414 (fax)
Education:
Medical School
Baylor College of Medicine
Graduated: 1986
Procedures:
Lens and Cataract Procedures, Ophthalmological Exam
Conditions:
Acute Conjunctivitis, Cataract, Diabetic Retinopathy, Glaucoma, Keratitis, Macular Degeneration, Primary Angle-Closure Glaucoma, Retinal Detachments
Languages:
English, Spanish
Description:
Dr. Ingram graduated from the Baylor College of Medicine in 1986. He works in Midland, TX and specializes in Ophthalmology.
Ronald Ingram Photo 2

Ronald William Ingram

Specialties:
Ophthalmology
Family Medicine
Education:
Baylor College of Medicine (1986)

Ronald Ingram resumes & CV records

Resumes

Ronald Ingram Photo 40

Security Officer

Location:
San Diego, CA
Work:

Security Officer
Education:
Palomar College
Ronald Ingram Photo 41

President

Location:
San Diego, CA
Industry:
Medical Devices
Work:
Integra Lifesciences
Vice President, Research and Development Telios Pharmaceuticals 1993 - 1995
Senior Scientist Mayo Clinic 1991 - 1993
Postdoctoral Fellow, Bone Metabolism Strategic Biomedical 1991 - 1993
President
Education:
University of California, Berkeley 1985 - 1991
Doctorates, Doctor of Philosophy, Physiology, Anatomy Uc Irvine 1985 - 1985
Bachelors, Bachelor of Science, Biology University of California
Skills:
Program Management, Tissue
Ronald Ingram Photo 42

Test Floorooerator

Work:
Abb
Test Floorooerator
Ronald Ingram Photo 43

Founder, President

Work:

Founder, President
Ronald Ingram Photo 44

Ronald Ingram

Ronald Ingram Photo 45

Ronald Ingram

Location:
United States

Publications & IP owners

Us Patents

Flowable Wound Matrix And Its Preparation And Use

US Patent:
8357402, Jan 22, 2013
Filed:
Jul 5, 2011
Appl. No.:
13/176174
Inventors:
Ronald T. Ingram - Encinitas CA, US
Jignesh B. Patel - Newtown PA, US
Timothy J. Pryor - Yardley PA, US
Assignee:
Integra LifeSciences Corporation - Plainsboro NJ
International Classification:
A61K 9/50
A61K 38/39
A61K 47/48
US Classification:
424499, 514 172
Abstract:
This invention relates to a flowable collagen/glycosaminoglycan (GAG) material including particles of collagen/GAG matrix that, when hydrated, can be effectively delivered to wounds having varying depths and geometries. The flowable collagen/GAG matrix allows a more intimate contact between the wound matrix and the wound bed, and provides a structural framework that serves as a scaffold for cell ingrowth.

Flowable Wound Matrix And Its Preparation And Use

US Patent:
7993679, Aug 9, 2011
Filed:
Sep 19, 2008
Appl. No.:
12/233936
Inventors:
Ronald T. Ingram - Encinitas CA, US
Jignesh B. Patel - Newtown PA, US
Timothy J. Pryor - Yardley PA, US
Assignee:
Integra LifeSciences Corporation - Plainsboro NJ
International Classification:
A61K 9/50
A61K 38/39
A61K 47/48
US Classification:
424499, 514 172
Abstract:
This invention relates to a flowable collagen/glycosaminoglycan (GAG) material including particles of collagen/GAG matrix that, when hydrated, can be effectively delivered to wounds having varying depths and geometries. The flowable collagen/GAG matrix allows a more intimate contact between the wound matrix and the wound bed, and provides a structural framework that serves as a scaffold for cell ingrowth.

Use Of Peptides For Altering Bone Resorption

US Patent:
5792745, Aug 11, 1998
Filed:
Apr 12, 1995
Appl. No.:
8/421697
Inventors:
Soan Cheng - San Diego CA
Ronald Ingram - Oceanside CA
Daniel Mullen - San Diego CA
Juerg F. Tschopp - San Diego CA
Assignee:
La Jolla Cancer Research Center - La Jolla CA
International Classification:
A61K 3808
A61K 3812
C07K 706
C07K 754
US Classification:
514 11
Abstract:
The present invention provides Arg-Gly-Asp peptides that can alter the binding of osteoclasts to a matrix such as bone or can selectively alter integrin receptor binding. The invention also provides methods of using the Arg-Gly-Asp peptides to alter. alpha. sub. v. beta. sub. 3 integrin receptor-mediated binding of a cell such as an osteoclast, endothelial cell or smooth muscle cell to a matrix. The invention further provides methods for ameliorating the severity of a pathology characterized, in part, by an undesirable level of bone resorption, angiogenesis or restenosis in a subject.

Peptides Useful For Altering .Alpha..sub.v .Beta..sub.3 -Mediated Binding

US Patent:
5759996, Jun 2, 1998
Filed:
Apr 12, 1995
Appl. No.:
8/421702
Inventors:
Soan Cheng - San Diego CA
Ronald Ingram - Oceanside CA
Daniel Mullen - San Diego CA
Juerg F. Tschopp - San Diego CA
Assignee:
La Jolla Cancer Research Center - La Jolla CA
International Classification:
A61K 3808
A61K 3810
A61K 3812
A61K 3816
US Classification:
514 11
Abstract:
The present invention provides Arg-Gly-Asp peptides that can alter the binding of osteoclasts to a matrix such as bone or can selectively alter integrin receptor binding. The invention also provides methods of using the Arg-Gly-Asp peptides to alter. alpha. sub. v. beta. sub. 3 integrin receptor-mediated binding of a cell such as an osteoclast, endothelial cell or smooth muscle cell to a matrix. The invention further provides methods for ameliorating the severity of a pathology characterized, in part, by an undesirable level of bone resorption, angiogenesis or restenosis in a subject.

Peptides Useful For Altering Bone Resorption

US Patent:
5807819, Sep 15, 1998
Filed:
Apr 12, 1995
Appl. No.:
8/421698
Inventors:
Soan Cheng - San Diego CA
Ronald Ingram - Oceanside CA
Daniel Mullen - San Diego CA
Juerg F. Tschopp - San Diego CA
Assignee:
La Jolla Cancer Research Center - La Jolla CA
International Classification:
A61K 3808
A61K 3810
A61K 3812
A61K 3816
US Classification:
514 11
Abstract:
The present invention provides Arg--Gly--Asp peptides that can alter the binding of osteoclasts to a matrix such as bone or can selectively alter integrin receptor binding. The invention also provides methods of using the Arg--Gly--Asp peptides to alter. alpha. sub. V. beta. sub. 3 integrin receptor-mediated binding of a cell such as an osteoclast, endothelial cell or smooth muscle cell to a matrix. The invention further provides methods for ameliorating the severity of a pathology characterized, in part, by an undesirable level of bone resorption, angiogenesis or restenosis in a subject.

Peptides For Altering Bone Resorption, Angiogenesis And Restenosis

US Patent:
5849865, Dec 15, 1998
Filed:
Apr 12, 1995
Appl. No.:
8/421695
Inventors:
Soan Cheng - San Diego CA
Ronald Ingram - Oceanside CA
Daniel Mullen - San Diego CA
Juerg F. Tschopp - San Diego CA
Assignee:
La Jolla Cancer Research Foundation - San Diego CA
International Classification:
A61K 3808
C07K 706
C07K 707
C07K 754
US Classification:
530317
Abstract:
The present invention provides Arg-Gly-Asp peptides that can alter the binding of osteoclasts to a matrix such as bone or can selectively alter integrin receptor binding. The invention also provides methods of using the Arg-Gly-Asp peptides to alter. alpha. sub. v. beta. sub. 3 integrin receptor-mediated binding of a cell such as an osteoclast, endothelial cell or smooth muscle cell to a matrix. The invention further provides methods for ameliorating the severity of a pathology characterized, in part, by an undesirable level of bone resorption, angiogenesis or restenosis in a subject.

Use Of Peptides For Altering .Alpha..sub.v .Beta..sub.3 -Mediated Binding

US Patent:
5773412, Jun 30, 1998
Filed:
Apr 12, 1995
Appl. No.:
8/421696
Inventors:
Soan Cheng - San Diego CA
Ronald Ingram - Oceanside CA
Daniel Mullen - San Diego CA
Juerg F. Tschopp - San Diego CA
Assignee:
La Jolla Cancer Research Center - La Jolla CA
International Classification:
A61K 3808
A61K 3810
A61K 3812
A61K 3816
US Classification:
514 11
Abstract:
The present invention provides Arg--Gly--Asp peptides that can alter the binding of osteoclasts to a matrix such as bone or can selectively alter integrin receptor binding. The invention also provides methods of using the Arg--Gly--Asp peptides to alter. alpha. sub. v. beta. sub. 3 integrin receptor-mediated binding of a cell such as an osteoclast, endothelial cell or smooth muscle cell to a matrix. The invention further provides methods for ameliorating the severity of a pathology characterized, in part, by an undesirable level of bone resorption, angiogenesis or restenosis in a subject.

Peptides For Reducing Or Inhibiting Bone Resorption

US Patent:
5770565, Jun 23, 1998
Filed:
Sep 8, 1994
Appl. No.:
8/303052
Inventors:
Soan Cheng - San Diego CA
Ronald Ingram - Oceanside CA
Daniel Mullen - San Diego CA
Juerg Tschopp - San Diego CA
Assignee:
La Jolla Cancer Research Center - La Jolla CA
International Classification:
A61K 3808
A61K 3810
C07K 706
C07K 708
US Classification:
514 11
Abstract:
The present invention provides Arg-Gly-Asp peptides that can reduce or inhibit the binding of osteoclasts to a matrix such as bone or can selectively alter integrin receptor binding. The invention also provides methods of using the Arg-Gly-Asp peptides to reduce or inhibit osteoclast binding to a matrix, to reduce or inhibit bone resorption in a subject and to alter. alpha. sub. V. beta. sub. 3 binding.

Possible Relatives

Cynthia K Ingram  David A Ingram  Dayna E Ingram  Deana M Ingram  Daisy B Ingram  Damian Ingram  Damon Ingram  Ronald W Johnson  Ronald R Stamps  Ronald L Stancill 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.